Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

An Interdisciplinary Consensus Approach to Pulmonary Hypertension in Developmental Lung Disorders.

  • Read more about An Interdisciplinary Consensus Approach to Pulmonary Hypertension in Developmental Lung Disorders.

VIEWING PULMONARY HYPERTENSION THROUGH A PEDIATRIC LENS.

  • Read more about VIEWING PULMONARY HYPERTENSION THROUGH A PEDIATRIC LENS.

WNT7A deficit is associated with dysfunctional angiogenesis in pulmonary arterial hypertension.

  • Read more about WNT7A deficit is associated with dysfunctional angiogenesis in pulmonary arterial hypertension.

Macrophage-derived IL-6 trans-signalling as a novel target in the pathogenesis of bronchopulmonary dysplasia.

  • Read more about Macrophage-derived IL-6 trans-signalling as a novel target in the pathogenesis of bronchopulmonary dysplasia.

Characterisation of Pediatric Pulmonary Hypertensive Vascular Disease from the PPHNet Registry.

  • Read more about Characterisation of Pediatric Pulmonary Hypertensive Vascular Disease from the PPHNet Registry.

Temporal airway microbiome changes related to ventilator-associated pneumonia in children.

  • Read more about Temporal airway microbiome changes related to ventilator-associated pneumonia in children.

Acute hypoxaemic respiratory failure in immunocompromised patients: abandon bronchoscopy or make it better?

  • Read more about Acute hypoxaemic respiratory failure in immunocompromised patients: abandon bronchoscopy or make it better?

Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension.

  • Read more about Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension.

Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension.

  • Read more about Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension.

Breathing and pulmonary surfactant function in mice 24 h after ozone exposure.

  • Read more about Breathing and pulmonary surfactant function in mice 24 h after ozone exposure.
Subscribe to The European respiratory journal

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List